Vincerx Pharma Inc
General ticker "VINC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $10.4M
Vincerx Pharma Inc does not follow the US Stock Market performance with the rate: -19.2%.
Estimated limits based on current volatility of 5.7%: low 0.19$, high 0.22$
Factors to consider:
- Company does not operate outside North America (retrieved using AI)
- Current price 64.6% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.56$, 1.68$]
- 2024-12-30 to 2025-12-30 estimated range: [0.60$, 1.74$]
Financial Metrics affecting the VINC estimates:
- Negative: Non-GAAP EPS, $ of -2.22 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -73.57 <= 2.35
- Positive: Inventory ratio change, % of -200 <= -1.03
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term VINC quotes
Long-term VINC plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $62.66MM | $73.57MM | $42.61MM |
| Operating Income | $-62.66MM | $-73.57MM | $-42.61MM |
| Non-Operating Income | $23.35MM | $8.21MM | $2.45MM |
| R&D Expense | $40.08MM | $52.15MM | $28.97MM |
| Income(Loss) | $-39.31MM | $-65.37MM | $-40.16MM |
| Profit(Loss) | $-39.31MM | $-65.37MM | $-40.16MM |
| Stockholders Equity | $100.32MM | $47.67MM | $11.22MM |
| Inventory | $0.00MM | $1.24MM | $0.00MM |
| Assets | $117.68MM | $59.29MM | $18.22MM |
| Operating Cash Flow | $-33.40MM | $-59.60MM | $-40.45MM |
| Capital expenditure | $5.26MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-5.26MM | $-40.58MM | $41.50MM |
| Financing Cash Flow | $88.45MM | $0.28MM | $0.11MM |
| Earnings Per Share* | $-0.91 | $-2.72 | $-1.89 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.